Valneva soars on US market after promising results
Valneva's stock surged 15% on Wall Street after positive vaccine data was released.
Published 3sem1 sourceNotableupdated 3sem
Lire en français
≈ 16s
The fact
The French biotech firm published interim results on June 29, 2026.
This performance renews investor confidence in its therapeutic pipeline.
Click the link to read an article on the topic: